Q-Med starts study within new medical area
Q-Med starts study within new medical area Q-Med has obtained approval from the Swedish Medical Products Agency to begin a study on patients with GastroEsophageal Reflux Disease, GERD. GERD (GastroEsophageal Reflux Disease) involves gastric juice content leaking from the stomach up into the esophagus, causing heartburn, amongst other things. "This is a very interesting market for us. 15 - 20 percent of the population suffer from this problem at least once per week and seven percent have problems daily," says Bengt Ågerup, Q-Med's President and CEO. In the study a gel consisting of NASHA and